KRAS and non-small cell lung carcinoma: Herein, we conducted a comprehensive systematic review and meta-analysis of available studies that compare the concordance between results on cfDNA within liquid biopsy and genomic DNA within tumor tissue to obtain an all-inclusive evaluation of the diagnostic accuracy of cfDNA testing for detection of KRAS mutations in NSCLC patients.